Goldman SachsGSCOMMENTJul 17, 2013Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
Has suffered off its previous 2008 highs but in the last year it has done very well. Recovering along with a lot of the banks. We still haven’t hit a capital markets cycle, which is unusual. Usually capital markets cycle and the M&A cycle is coincidental with the success of the market move. It will happen but not yet. This bank will be a prime recipient when it does.